InMode develops and sells energy-based medical aesthetic devices used for minimally invasive and non-invasive body and facial treatments. Its platforms typically combine radiofrequency and related technologies for fat reduction, skin tightening and other cosmetic procedures performed in clinics and medspas. Customers are primarily aesthetic physicians and practices rather than hospital systems or pharmaceutical channels.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 95.6 | — | 26.7 | -7% |
| Q3 2025 | 93.2 | — | 21.9 | -60.2% |
| Q4 2025 | 103.8 | — | 27 | -17.2% |
| Q1 2026 | 82 | — | 11.6 | -46.4% |
| Q2 2026 | 95.6 | -0% | 17.1 | -36.2% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: MoonLake Immunotherapeutics (MLTX), Kura Oncology, Inc. (KURA), Playtika Holding Corp. (PLTK), SpyGlass Pharma, Inc. (SGP), Corvus Pharmaceuticals, Inc. (CRVS), World Acceptance Corporation (WRLD)